Is there a racial difference in presentation of primary hyperparathyroidism?

Area of Science:

• Endocrinology
• Surgical Research
• Health Disparities

Background:

• Primary hyperparathyroidism (PHPT) affects nearly 50,000 individuals annually in the U.S.
• Existing research on PHPT predominantly focuses on the white population.
• Racial differences in PHPT presentation and outcomes require further investigation.

Purpose of the Study:

• To investigate potential racial differences in the clinical presentation of primary hyperparathyroidism.
• To compare demographic, laboratory, and symptomatic data between African American and white patients undergoing surgical treatment for PHPT.

Main Methods:

• Retrospective chart review of 286 patients surgically treated for PHPT between 1997 and 2002.
• African American patients were matched to white patients by age and gender.
• Statistical analysis included ANOVA and chi-squared tests, with regression models to adjust for matching variables.

Main Results:

• African Americans constituted 14.4% of the study cohort.
• No significant differences were observed in serum calcium levels or the presence of objective symptoms between racial groups.
• African American patients exhibited significantly higher parathyroid hormone (PTH) levels (207.5 vs. 143.5 pg/mL, P = 0.02) at the time of surgical intervention.

Conclusions:

• African American patients with PHPT present with significantly elevated PTH levels compared to white patients.
• Despite higher PTH levels, African American patients do not appear to have differences in symptoms or disease advancement at surgery.
• Further research is recommended to elucidate ethnic variations in PHPT and inform tailored clinical approaches.